Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase NA 17Phase 1 11Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 3Phase 1/2 3

Status

Withdrawn 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Dysplasia 1Prostatic Neoplasms 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Curcumin × Clear all
NCT02724202 2026-02-06

Curcumin in Combination With 5FU for Colon Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Terminated
15 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02554344 2026-01-30

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Baylor Research Institute

Phase EARLY_PHASE1 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

NCT04403568 2021-09-16

Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡